drugset / Trial / NCT01948622

Anxiety Control by Erythrina Mulungu

NCT01948622

RandomizedCrossoverQuadruple-blindTreatment

Summary

This study evaluated the effectiveness of the Erythrina mulungu in controlling anxiety in patients undergoing bilateral extraction of asymptomatic, impacted mandibular third molars.

Timeline

Start
2012-01
Primary completion
2012-06
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mulungu Unknown 500 mg Oral